COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View.

El Desoky, Ehab S

El Desoky, Ehab S.

El Desoky ES; Faculty of Medicine, Assiut University, Assiut, Egypt.

Am J Ther ; 28(1): e136-e139, 2021.

Article in English | MEDLINE | ID: covidwho-998553

Subject(s)

COVID-19/genetics; Pharmacogenetics; Renin-Angiotensin System; Angiotensin II/blood; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2/genetics; Angiotensin-Converting Enzyme 2/metabolism; Angiotensin-Converting Enzyme Inhibitors; Animals; COVID-19/epidemiology; COVID-19/physiopathology; Genotype; Humans; Mice

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmacogenetics / Renin-Angiotensin System / COVID-19 Type of study: Observational study Limits: Animals / Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: MJT.0000000000001299

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google